{"id":4318,"date":"2022-08-09T07:34:13","date_gmt":"2022-08-09T07:34:13","guid":{"rendered":"https:\/\/aceoncology.org\/?p=4318"},"modified":"2022-08-09T07:34:21","modified_gmt":"2022-08-09T07:34:21","slug":"no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer","status":"publish","type":"post","link":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/","title":{"rendered":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f"},"content":{"rendered":"\n<p>\u5b50\u5bab\u5185\u819c\u764c\u662f\u6b27\u6d32\u6700\u5e38\u89c1\u7684\u5987\u79d1\u80bf\u7624\u4e4b\u4e00\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u5927\u591a\u6570\u60a3\u8005\u8868\u73b0\u4e3a\u53ef\u624b\u672f\u75be\u75c5\uff0c\u9884\u540e\u826f\u597d\uff0c5\u5e74\u76f8\u5bf9\u751f\u5b58\u7387\u4e3a76%\u3002\u624b\u672f\u8054\u5408\u6216\u4e0d\u8054\u5408\u8f85\u52a9\u6cbb\u7597\u540e\uff0c\u73b0\u884c\u6307\u5357\u5efa\u8bae\u968f\u8bbf5\u5e74\uff0c\u524d2\u5e74\u8fdb\u6bcf3-4\u4e2a\u6708\u8fdb\u884c1\u6b21\u533b\u9662\u8bbf\u89c6\uff0c\u5176\u4f593\u5e74\u6bcf6-12\u4e2a\u6708\u8fdb\u884c1\u6b21\u3002\u7136\u800c\uff0c\u4e34\u5e8a\u5b9e\u8df5\u4e2d\u5bf9\u6307\u5357\u7684\u4f9d\u4ece\u6027\u548c\u6cbb\u7597\u540e\u968f\u8bbf\u5f3a\u5ea6\u5177\u6709\u9ad8\u5ea6\u4e0d\u4e00\u81f4\u6027\u3002\u867d\u7136\u968f\u673a\u5bf9\u7167\u4e34\u5e8a\u8bd5\u9a8c\u7814\u7a76\u4e86\u8ba1\u5212\u8bbf\u89c6\u6b21\u6570\u7684\u51cf\u5c11\u548c\u62a4\u58eb\u4e3b\u5bfc\u7684\u7535\u8bdd\u968f\u8bbf\u7684\u4f5c\u7528\uff0c\u4f46\u5c1a\u672a\u7814\u7a76\u5f3a\u5316\u968f\u8bbf\uff08\u5305\u62ec\u5e38\u89c4\u8840\u6e05\u3001\u7ec6\u80de\u5b66\u68c0\u67e5\u548c\u5f71\u50cf\u5b66\u626b\u63cf\uff09\u5bf9\u603b\u751f\u5b58\u671f \uff08OS\uff09 \u7684\u5f71\u54cd\u3002<\/p>\n\n\n\n<p>\u6700\u8fd1\u53d1\u8868\u7684 TOTEM \u7814\u7a76\u89e3\u51b3\u4e86\u8fd9\u4e00\u95ee\u9898\uff0c<a href=\"https:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.22.00471\">TOTEM\u7814\u7a76<\/a>\u662f\u4e00\u9879\u5728\u610f\u5927\u5229\u548c\u6cd5\u56fd42\u5bb6\u56fd\u5bb6\u536b\u751f\u670d\u52a1\u533b\u9662\u8fdb\u884c\u7684\u5927\u578b\u3001\u968f\u673a\u3001\u5b9e\u7528\u3001\u5e73\u884c\u5206\u7ec4\u8bd5\u9a8c\u3002\u8be5\u7814\u7a76\u8bd5\u56fe\u63a2\u7d22\u5728\u624b\u672f\u6cbb\u7597\u7684\u5b50\u5bab\u5185\u819c\u764c\u60a3\u8005\u4e2d\uff0c\u4e0e\u6700\u4f4e\u9650\u5ea6\u76845\u5e74\u533b\u9662\u968f\u8bbf\u76f8\u6bd4\uff0c\u5f3a\u5316\u968f\u8bbf\u65b9\u6cd5\u662f\u5426\u80fd\u6539\u5584OS\u3002\u968f\u673a\u5316\u524d\uff0c\u6839\u636e FIGO \u5206\u7c7b\uff0c\u6309\u4e2d\u5fc3\u548c\u590d\u53d1\u98ce\u9669\uff08\u4f4e\u98ce\u9669\u4e0e\u9ad8\u98ce\u9669\uff09\u5bf9\u60a3\u8005\u8fdb\u884c\u5206\u5c42\u3002\u4f4e\u98ce\u9669\u60a3\u8005\u7684\u6700\u4f4e\u968f\u8bbf\u65b9\u6848\u5305\u62ec11\u6b21\u8bbf\u89c6\uff0c\u8fdb\u884c\u4e00\u822c\u68c0\u67e5\u548c\u5987\u79d1\u68c0\u67e5\uff0c\u4f46\u65e0\u8840\u6e05\u5b66\u3001\u9634\u9053\u7ec6\u80de\u5b66\u6216\u5f71\u50cf\u5b66\u68c0\u67e5\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u4f4e\u98ce\u9669\u60a3\u8005\u7684\u5f3a\u5316\u968f\u8bbf\u5305\u62ec13\u6b21\u8bbf\u89c6\u548c\u6bcf\u5e74\u989d\u5916\u7684\u9634\u9053\u7ec6\u80de\u5b66\u68c0\u67e5\uff0c\u4ee5\u53ca\u5728\u524d2\u5e74\u8fdb\u884c\u6bcf\u5e74\u7684\u80f8\u90e8\u3001\u8179\u90e8\u548c\u9aa8\u76c6\u8ba1\u7b97\u673a\u65ad\u5c42\u626b\u63cf \uff08CT\uff09\u3002\u5bf9\u4e8e\u9ad8\u5371\u60a3\u8005\uff0c\u6781\u7b80\u968f\u8bbf\u5305\u62ec\u524d2\u5e74\u768413\u6b21\u8bbf\u89c6\u548c\u6bcf\u5e741\u6b21\u7684 CT \u626b\u63cf\uff0c\u800c\u8fd9\u4e9b\u60a3\u8005\u7684\u5f3a\u5316\u968f\u8bbf\u65b9\u6848\u5305\u62ec\u6bcf\u6b21\u8bbf\u89c6\u65f6\u8fdb\u884c14\u6b21\u8840\u6e05\u764c\u6297\u539f 125\uff08CA-125\uff09 \u68c0\u6d4b\uff0c\u6bcf\u5e742\u6b21\u8179\u90e8\u548c\u76c6\u8154\u8d85\u58f0\u68c0\u67e5\u548c\u6bcf\u5e741\u6b21\u7684\u9634\u9053\u7ec6\u80de\u5b66\u548c CT \u626b\u63cf\uff0c\u6301\u7eed3\u5e74\u3002<\/p>\n\n\n\n<p>\u5728\u7eb3\u5165\u5206\u6790\u76841847\u4f8b\u60a3\u8005\u4e2d\uff0c\u6700\u5c0f\u548c\u5bc6\u96c6\u968f\u8bbf\u7ec4\u5e74\u9f84\u3001\u5206\u671f\u548c\u7ec4\u7ec7\u5b66\u4e9a\u578b\u7b49\u57fa\u7ebf\u7279\u5f81\u5e73\u8861\u3002\u4e2d\u4f4d\u968f\u8bbf\u65f6\u95f4\u4e3a69\u4e2a\u6708\u3002\u603b\u4f535\u5e74 OS \u7387\u4e3a91.3%\uff0c198\u4f8b\u60a3\u8005\u6b7b\u4ea1\u3002\u63a5\u53d7\u5f3a\u5316\u968f\u8bbf\u4e0e\u6700\u4f4e\u968f\u8bbf\u7684\u60a3\u8005\u76845\u5e74 OS \u65e0\u5dee\u5f02\uff0890.6%vs. 91.9%\uff1b\u98ce\u9669\u6bd4 [HR]\uff0c1.13\uff1bP = 0.380\uff09\u3002\u540c\u6837\uff0c\u6839\u636e\u98ce\u9669\u5206\u7ec4\u8fdb\u884c\u7684\u5f3a\u5316\u4e0e\u6700\u4f4e\u968f\u8bbf\u76845\u5e74 OS \u6bd4\u8f83\u663e\u793a\u65e0\u5dee\u5f02\uff1a\u4f4e\u98ce\u9669\u7ec4\uff08\u5206\u522b\u4e3a94.1%\u4e0e96.8%\uff1bHR\uff0c1.45\uff1bP = 0.121\uff09\uff1b\u9ad8\u98ce\u9669\u7ec4\uff08\u5206\u522b\u4e3a85.3%\u4e0e84.7%\uff08HR\uff0c0.99\uff1bP = 0.936\uff09\u3002\u6b64\u5916\uff0c\u8003\u8651\u5e74\u9f84\u3001\u764c\u75c7\u6cbb\u7597\u3001\u590d\u53d1\u98ce\u9669\u548c\u4e2d\u5fc3\u4f9d\u4ece\u6027\u7684\u4e9a\u7ec4\u5206\u6790\u663e\u793a\u5f3a\u5316\u968f\u8bbf\u65e0\u83b7\u76ca\u3002<\/p>\n\n\n\n<p>\u5171\u6709175\u4f8b\u60a3\u8005\uff08\u4f4e\u5371\u7ec451\u4f8b\uff0c\u9ad8\u5371\u7ec4124\u4f8b\uff09\u53d1\u751f\u75be\u75c5\u590d\u53d1\u3002\u5927\u591a\u6570\u590d\u53d1\u5728\u968f\u8bbf\u7684\u524d2\u5e74\u5185\u88ab\u8bca\u65ad\uff0c\u8bca\u65ad\u590d\u53d1\u7684\u4e2d\u4f4d\u65f6\u95f4\u4e3a14\u4e2a\u6708\uff08\u4f4e\u5371\u7ec4\u4e3a23\u4e2a\u6708\uff0c\u9ad8\u5371\u7ec4\u4e3a12\u4e2a\u6708\uff09\u3002\u5f3a\u5316\u968f\u8bbf\u4e0e\u6700\u4f4e\u968f\u8bbf\u76845\u5e74\u65e0\u590d\u53d1\u751f\u5b58\u7387\u5206\u522b\u4e3a90.7%\u4e0e93.7%\uff08HR\uff0c1.17\uff1bP = 0.194\uff09\u3002\u7ea6\u534a\u6570\u590d\u53d1\u65e0\u75c7\u72b6\u3002\u5927\u591a\u6570\u590d\u53d1\u901a\u8fc7\u8bbf\u89c6\u548c CT \u626b\u63cf\u68c0\u6d4b\u5230 \uff0850.8%\uff09\u3002\u5728\u63a5\u53d7\u5f3a\u5316\u968f\u8bbf\u7684\u5973\u6027\u4e2d\uff0c\u590d\u53d1\u7684\u68c0\u51fa\u7387\u7565\u9ad8\uff0c\u5c24\u5176\u662f\u65e0\u75c7\u72b6\u590d\u53d1\uff0c\u4f46\u8fd9\u79cd\u65e9\u671f\u68c0\u6d4b\u5e76\u4e0d\u80fd\u8f6c\u5316\u4e3a OS \u6539\u5584\u3002\u5f3a\u5316\u968f\u8bbf\u7ec4\u60a3\u8005\u5bf9\u8ba1\u5212\u8bbf\u89c6\u7684\u4f9d\u4ece\u6027 \uff0865.5%\uff09 \u7565\u4f4e\u4e8e\u6700\u4f4e\u968f\u8bbf\u7ec4 \uff0869.5%\uff1bP = 0.048\uff09\u3002<\/p>\n\n\n\n<p>TOTEM \u7814\u7a76\u7684\u4f5c\u8005\u5f97\u51fa\u7ed3\u8bba\uff0c\u8be5\u7814\u7a76\u201c\u6e05\u695a\u5730\u8868\u660e\uff0c\u5bf9\u63a5\u53d7\u5b50\u5bab\u5185\u819c\u764c\u6cbb\u7597\u7684\u60a3\u8005\u8fdb\u884c\u5f3a\u5316\u968f\u8bbf\u5e76\u4e0d\u80fd\u6539\u5584OS\uff0c\u5373\u4fbf\u662f\u5728\u9ad8\u5371\u60a3\u8005\u4e2d\u4e5f\u662f\u5982\u6b64\u201d\u3002\u6b64\u5916\uff0c\u8fd9\u4e9b\u7ed3\u679c\u201c\u589e\u52a0\u4e86\u5f3a\u6709\u529b\u7684\u8bc1\u636e\uff0c\u4ee5\u52a0\u5f3a\u6307\u5357\u5efa\u8bae\u4e2d\u9f13\u52b1\u8fdb\u884c\u6700\u4f4e\u9650\u5ea6\u968f\u8bbf\u7684\u73b0\u6709\u8d8b\u52bf\uff0c\u5305\u62ec\u5728\u524d\u4e24\u5e74\u5185\u5bf9\u9ad8\u98ce\u9669\u60a3\u8005\u8fdb\u884c\u8ba1\u5212\u7684\u4e34\u5e8a\u8bbf\u89c6\u4ee5\u53ca\u80f8\u90e8\u3001\u8179\u90e8\u548c\u9aa8\u76c6\u8ba1\u7b97\u673a\u65ad\u5c42\u626b\u63cf\u201d\u3002<\/p>\n\n\n\n<p><strong>\u53c2\u8003\u6587\u732e<\/strong><strong><\/strong><\/p>\n\n\n\n<p>Zola P, et al. <em>J Clin Oncol.<\/em> 2022, July 20 [Online ahead of print].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5b50\u5bab\u5185\u819c\u764c\u662f\u6b27\u6d32\u6700\u5e38\u89c1\u7684\u5987\u79d1\u80bf\u7624\u4e4b\u4e00\u3002\u5e78\u8fd0\u7684\u662f\uff0c\u5927\u591a\u6570\u60a3\u8005\u8868\u73b0\u4e3a\u53ef\u624b\u672f\u75be\u75c5\uff0c\u9884\u540e\u826f\u597d\uff0c5\u5e74\u76f8\u5bf9\u751f\u5b58\u7387\u4e3a76%\u3002 [&hellip;]<\/p>\n","protected":false},"author":691,"featured_media":4307,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4318","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology<\/title>\n<meta name=\"description\" content=\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology\" \/>\n<meta property=\"og:description\" content=\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"ACE Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-09T07:34:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-09T07:34:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"803\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"j gao\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:site\" content=\"@ace_oncology\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"j gao\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\"},\"author\":{\"name\":\"j gao\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\"},\"headline\":\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f\",\"datePublished\":\"2022-08-09T07:34:13+00:00\",\"dateModified\":\"2022-08-09T07:34:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\"},\"wordCount\":40,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg\",\"articleSection\":[\"\u6587\u7ae0\u7cbe\u8981\"],\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\",\"url\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\",\"name\":\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/aceoncology.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg\",\"datePublished\":\"2022-08-09T07:34:13+00:00\",\"dateModified\":\"2022-08-09T07:34:21+00:00\",\"description\":\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f\",\"breadcrumb\":{\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg\",\"width\":1000,\"height\":803},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"ACE Oncology\",\"item\":\"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/aceoncology.org\/#website\",\"url\":\"https:\/\/aceoncology.org\/\",\"name\":\"ACE Oncology\",\"description\":\"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.\",\"publisher\":{\"@id\":\"https:\/\/aceoncology.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/aceoncology.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/aceoncology.org\/#organization\",\"name\":\"ACE Oncology\",\"url\":\"https:\/\/aceoncology.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"contentUrl\":\"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png\",\"width\":156,\"height\":83,\"caption\":\"ACE Oncology\"},\"image\":{\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/ace_oncology\",\"https:\/\/www.linkedin.com\/company\/aceoncology\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf\",\"name\":\"j gao\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\/\/aceoncology.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g\",\"caption\":\"j gao\"},\"url\":\"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology","description":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/","og_locale":"zh_CN","og_type":"article","og_title":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology","og_description":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f","og_url":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/","og_site_name":"ACE Oncology","article_published_time":"2022-08-09T07:34:13+00:00","article_modified_time":"2022-08-09T07:34:21+00:00","og_image":[{"width":1000,"height":803,"url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg","type":"image\/jpeg"}],"author":"j gao","twitter_card":"summary_large_image","twitter_creator":"@ace_oncology","twitter_site":"@ace_oncology","twitter_misc":{"\u4f5c\u8005":"j gao","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#article","isPartOf":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/"},"author":{"name":"j gao","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf"},"headline":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f","datePublished":"2022-08-09T07:34:13+00:00","dateModified":"2022-08-09T07:34:21+00:00","mainEntityOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/"},"wordCount":40,"commentCount":0,"publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg","articleSection":["\u6587\u7ae0\u7cbe\u8981"],"inLanguage":"zh-Hans","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/","url":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/","name":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f - ACE Oncology","isPartOf":{"@id":"https:\/\/aceoncology.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage"},"image":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg","datePublished":"2022-08-09T07:34:13+00:00","dateModified":"2022-08-09T07:34:21+00:00","description":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f","breadcrumb":{"@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#primaryimage","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2022\/08\/Blog-Post-Picture-97.jpg","width":1000,"height":803},{"@type":"BreadcrumbList","@id":"https:\/\/aceoncology.org\/zh-hans\/no-benefit-of-intensive-follow-up-in-operated-endometrial-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"ACE Oncology","item":"https:\/\/aceoncology.org\/zh-hans\/chinese-home\/"},{"@type":"ListItem","position":2,"name":"\u5f3a\u5316\u968f\u8bbf\u4e0d\u80fd\u6539\u5584\u5b50\u5bab\u5185\u819c\u764c\u7684\u751f\u5b58\u671f"}]},{"@type":"WebSite","@id":"https:\/\/aceoncology.org\/#website","url":"https:\/\/aceoncology.org\/","name":"ACE Oncology","description":"ACE Oncology is a global independent medical education resource that provides evidence-based, high-quality educational solutions for clinicians that treat patients with cancer.","publisher":{"@id":"https:\/\/aceoncology.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/aceoncology.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/aceoncology.org\/#organization","name":"ACE Oncology","url":"https:\/\/aceoncology.org\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/","url":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","contentUrl":"https:\/\/aceoncology.org\/wp-content\/uploads\/2021\/05\/Logo.png","width":156,"height":83,"caption":"ACE Oncology"},"image":{"@id":"https:\/\/aceoncology.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ace_oncology","https:\/\/www.linkedin.com\/company\/aceoncology"]},{"@type":"Person","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/ccad8f084cde5a6cf908e3c506262fdf","name":"j gao","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/aceoncology.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afe10fca3d4cc45c0cd0b8bf85070e61056e2c5e5c887f814736bbe9e6243d1e?s=96&d=mm&r=g","caption":"j gao"},"url":"https:\/\/aceoncology.org\/zh-hans\/author\/jgao\/"}]}},"_links":{"self":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/users\/691"}],"replies":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/comments?post=4318"}],"version-history":[{"count":1,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4318\/revisions"}],"predecessor-version":[{"id":4319,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/posts\/4318\/revisions\/4319"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media\/4307"}],"wp:attachment":[{"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/media?parent=4318"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/categories?post=4318"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aceoncology.org\/zh-hans\/wp-json\/wp\/v2\/tags?post=4318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}